| ■ 영문 제목 : Gene Synthesis Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MA101
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 1월
■ 페이지수 : 176
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 바이오
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,330,000 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,730,000 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,530,000 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Grand View Research사는 글로벌 유전자 합성 시장 규모가 2023년부터 2030년 사이에 연평균 16.1% 성장하여, 2030년에는 57.8억 달러에 달할 것으로 전망하고 있습니다. 본 조사 보고서는 글로벌 유전자 합성 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 산업 동향, 방법별 (고상 합성법, 칩 합성법, PCR 기반 효소 합성법) 분석, 서비스별 (항체 DNA 합성, 바이러스 DNA 합성, 기타) 분석, 용도별 (유전자 및 세포 치료제 개발, 백신 개발, 질환 진단, 기타) 분석, 최종 용도별 (바이오테크놀러지 및 제약 기업, 학술 및 정부 연구 기관, 수탁 연구 기관) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동/아프리카) 분석, 경쟁 현황 등의 내용을 게재하고 있습니다. 또한 본 자료는 GenScript, Brooks Automation, Inc. (GENEWIZ), Boster Biological Technology, Twist Bioscience, ProteoGenix, Inc., Biomatik, ProMab Biotechnologies, Inc., Thermo Fisher Scientific, Inc., Integrated DNA Technologies, Inc., OriGene Technologies, Inc. 와 같은 기업 정보를 포함하고 있습니다.
・조사 방법 및 범위
・개요
・산업 동향
・글로벌 유전자 합성 시장 규모 : 방법별
- 고상 합성법의 시장 규모
- 칩 합성법의 시장 규모
- PCR 기반 효소 합성법의 시장 규모
・글로벌 유전자 합성 시장 규모 : 서비스별
- 항체 DNA 합성 서비스의 시장 규모
- 바이러스 DNA 합성 서비스의 시장 규모
- 기타 서비스의 시장 규모
・글로벌 유전자 합성 시장 규모 : 용도별
- 유전자 및 세포 치료제 개발에 사용되는 유전자 합성의 시장 규모
- 백신 개발에 사용되는 유전자 합성의 시장 규모
- 질환 진단에 사용되는 유전자 합성의 시장 규모
- 기타 용도에 사용되는 유전자 합성의 시장 규모
・글로벌 유전자 합성 시장 규모 : 최종 용도별
- 바이오테크놀러지 및 제약 기업에서 사용되는 유전자 합성의 시장 규모
- 학술 및 정부 연구 기관에서 사용되는 유전자 합성의 시장 규모
- 수탁 연구 기관에서 사용되는 유전자 합성의 시장 규모
・글로벌 유전자 합성 시장 규모 : 지역별
- 북미의 유전자 합성 시장 규모
- 유럽의 유전자 합성 시장 규모
- 아시아 태평양의 유전자 합성 시장 규모
- 중남미의 유전자 합성 시장 규모
- 중동/아프리카의 유전자 합성 시장 규모
・경쟁 현황
・기업 정보 |
■ 보고서 개요Gene Synthesis Market Growth & Trends
The global gene synthesis market size is expected to reach USD 5.78 billion by 2030, registering a CAGR of 16.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. Development of the market is due to the growing investment in the synthetic biology field, favorable government regulations, and technological advancements in the gene synthesis market. In January 2022, synthetic DNA manufacturer Twist Bioscience announced plans of developing EDS technology at the J.P. Morgan Health Care Conference. The company established an enzymatic DNA synthesis technology that is novel, low-cost, scarless, and scalable.
The introduction of novel DNA synthesis platforms with technologically advanced specifications that address the increased demand of researchers is also contributing to the overall growth. For instance, in June 2021, DNA Script introduced the SYNTAX System, which is the nucleic acid printer based on EDS technology. Similarly, in December 2020, Evonetix Ltd. entered into a research collaboration with Analog Devices, Inc. Under the terms of the agreement, the companies collaborated on Evonetix’s Microelectromechanical System-based silicon chips’ improvement and commercial scale-up, as well as the development of a DNA desktop writer.
Researchers, as well as biotechnology and pharmaceutical corporations, have become increasingly interested in targeted therapy during recent years. It has become a popular method of disease management. In the near future, targeted therapy in conjunction with chemotherapy and immunotherapy is likely to develop significantly, presenting lucrative prospects for both emerging & established competitors in the gene synthesis market.
Key players are focusing on product development and are entering into partnerships and collaborations to expand their product offerings. For instance, In January 2022, Thermo Fisher Scientific, Inc. completed the acquisition of PeproTech, Inc.- a producer of antibodies and vectors. This acquisition may help the company strengthen its position in the market. Similarly, in July 2021, GenScript hosted the GenScript Gene & Cell Engineering Virtual Summit. This event focused on highlighting synthetic biology research to enhance protein design, drug discovery, and genome editing, enabling the company to increase its customer base.
Gene Synthesis Market Report Highlights
• The growth is attributed to the growing demand for the synthetic biology, coupled with increasing government support to offer funds for R&D initiatives in synthetic biology
• By method, solid-phase synthesis dominated in 2022 as it offers high accuracy and is a prominent technology for the applications in several fields and for various research purposes
• By services, antibody DNA synthesis dominated the gene synthesis market in 2022, owing to the presence of significant players such as Synbio offers services, Twist Bioscience Corporation, and others, offering services in this segment
• By application, the gene & cell therapy development segment dominated the gene synthesis market in 2022. This is attributed to the growing number of R&D programs for the development of cell and gene therapies
• By end-use, academic and government research institute dominated the gene synthesis market in 2022, as most of the gene synthesis process is performed in the research settings for clinical research and investigational programs
• North America captured the highest share in 2022 owing to the well-established molecular biology infrastructure along with the presence of a significant number of market players in the region
■ 보고서 목차Table of Contents
Chapter 1 Gene Synthesis Market: Methodology And Scope
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
1.7 Global Market: CAGR Calculation
1.8 Regional Market: CAGR Calculation
1.9 List Of Secondary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
1.11 List of Abbreviations
Chapter 2 Gene Synthesis Market: Executive Summary
2.1 Gene Synthesis Market: Market Outlook
2.1.1 Market Summary
Chapter 3 Gene Synthesis Market: Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Rising investment in synthetic biology market
3.3.1.2 Advent of enzymatic DNA synthesis process
3.3.1.3 Technological advancements in the DNA synthesis platforms
3.3.1.4 Declining price of DNA synthesis & sequencing
3.3.2 Market restraint Analysis
3.3.2.1 Lack of skilled professionals
3.3.2.2 Misuse of gene synthesis
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis – Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
Chapter 4 Gene Synthesis Market: Competitive Landscape
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.1.1 Market Differentiators
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2022
4.4 Public Companies
4.4.1 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
Chapter 5 Gene Synthesis Market: Method Business Analysis
5.1 Gene Synthesis Market: Method Movement Analysis
5.2 Solid-phase Synthesis
5.2.1 Solid-phase Synthesis market estimates and forecast, 2018 – 2030 (USD Million)
5.3 Chip-based Synthesis
5.3.1 Chip-based Synthesis market estimates and forecast, 2018 – 2030 (USD Million)
5.4 PCR-based Enzyme Synthesis
5.4.1 PCR-based Enzyme Synthesis market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 6 Gene Synthesis Market: Services Business Analysis
6.1 Gene Synthesis Market: Services Movement Analysis
6.2 Antibody DNA Synthesis
6.2.1 Antibody DNA Synthesis market estimates and forecast, 2018 – 2030 (USD Million)
6.3 Viral DNA Synthesis
6.3.1 Viral DNA Synthesis market estimates and forecast, 2018 – 2030 (USD Million)
6.4 Others
6.4.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 7 Gene Synthesis Market: Application Business Analysis
7.1 Gene Synthesis Market: Application Movement Analysis
7.2 Gene & Cell Therapy Development
7.2.1 Gene & Cell Therapy Development market estimates and forecast, 2018 – 2030 (USD Million)
7.3 Vaccine Development
7.3.1 Vaccine Development market estimates and forecast, 2018 – 2030 (USD Million)
7.4 Disease Diagnosis
7.4.1 Disease Diagnosis market estimates and forecast, 2018 – 2030 (USD Million)
7.5 Others
7.5.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8 Gene Synthesis Market: End-use Business Analysis
8.1 Gene Synthesis Market: End-use Movement Analysis
8.2 Biotechnology and Pharmaceutical Companies
8.2.1 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 – 2030 (USD Million)
8.3 Academic and Government Research Institutes
8.3.1 Academic And Government Research Institutes market estimates and forecast, 2018 – 2030 (USD Million)
8.4 Contract Research Organizations
8.4.1 Contract Research Organizations market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 9 Gene Synthesis Market: Regional Business Analysis
9.1 North America
9.1.1 Swot Analysis
9.1.1.1 North America Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.1.2 U.S.
9.1.2.1 Key Country Dynamics
9.1.2.2 Target Disease Prevalence
9.1.2.3 Competitive Scenario
9.1.2.4 Regulatory Framework
9.1.2.5 Reimbursement Scenario
9.1.2.6 U.S. Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.1.3 CANADA
9.1.3.1 Key Country Dynamics
9.1.3.2 Target Disease Prevalence
9.1.3.3 Competitive Scenario
9.1.3.4 Regulatory Framework
9.1.3.5 Reimbursement Scenario
9.1.3.6 Canada Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2 Europe
9.2.1 SWOT Analysis:
9.2.1.1 Europe Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.2 Germany
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 Competitive Scenario
9.2.2.4 Regulatory Framework
9.2.2.5 Reimbursement Scenario
9.2.2.6 Germany Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.3 UK
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Competitive Scenario
9.2.3.4 Regulatory Framework
9.2.3.5 Reimbursement Scenario
9.2.3.6 UK Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.4 FRANCE
9.2.4.1 Key Country Dynamics
9.2.4.2 Target Disease Prevalence
9.2.4.3 Competitive Scenario
9.2.4.4 Regulatory Framework
9.2.4.5 Reimbursement Scenario
9.2.4.6 France Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.5 Italy
9.2.5.1 Key Country Dynamics
9.2.5.2 Target Disease Prevalence
9.2.5.3 Competitive Scenario
9.2.5.4 Regulatory Framework
9.2.5.5 Reimbursement Scenario
9.2.5.6 Italy Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.6 Spain
9.2.6.1 Key Country Dynamics
9.2.6.2 Target Disease Prevalence
9.2.6.3 Competitive Scenario
9.2.6.4 Regulatory Framework
9.2.6.5 Reimbursement Scenario
9.2.6.6 Spain Cell & Gene Therapy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.7 Denmark
9.2.7.1 Key Country Dynamics
9.2.7.2 Target Disease Prevalence
9.2.7.3 Competitive Scenario
9.2.7.4 Regulatory Framework
9.2.7.5 Reimbursement Scenario
9.2.7.6 Denmark Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.8 Sweden
9.2.8.1 Key Country Dynamics
9.2.8.2 Target Disease Prevalence
9.2.8.3 Competitive Scenario
9.2.8.4 Regulatory Framework
9.2.8.5 Reimbursement Scenario
9.2.8.6 Sweden Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.9 Norway
9.2.9.1 Key Country Dynamics
9.2.9.2 Target Disease Prevalence
9.2.9.3 Competitive Scenario
9.2.9.4 Regulatory Framework
9.2.9.5 Reimbursement Scenario
9.2.9.6 Norway Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3 Asia Pacific
9.3.1 Swot Analysi:
9.3.1.1 Key Region Dynamics
9.3.1.2 Asia Pacific Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.2 Japan
9.3.2.1 Target Disease Prevalence
9.3.2.2 Competitive Scenario
9.3.2.3 Regulatory Framework
9.3.2.4 Reimbursement Scenario
9.3.2.5 Japan Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.3 China
9.3.3.1 Target Disease Prevalence
9.3.3.2 Competitive Scenario
9.3.3.3 Regulatory Framework
9.3.3.4 Reimbursement Scenario
9.3.3.5 China Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.4 India
9.3.4.1 Target Disease Prevalence
9.3.4.2 Competitive Scenario
9.3.4.3 Regulatory Framework
9.3.4.4 Reimbursement Scenario
9.3.4.5 India Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.5 South Korea
9.3.5.1 Target Disease Prevalence
9.3.5.2 Competitive Scenario
9.3.5.3 Regulatory Framework
9.3.5.4 Reimbursement Scenario
9.3.5.5 South Korea Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.6 Australia
9.3.6.1 Target Disease Prevalence
9.3.6.2 Competitive Scenario
9.3.6.3 Regulatory Framework
9.3.6.4 Reimbursement Scenario
9.3.6.5 Australia Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.7 Thailand
9.3.7.1 Target Disease Prevalence
9.3.7.2 Competitive Scenario
9.3.7.3 Regulatory Framework
9.3.7.4 Reimbursement Scenario
9.3.7.5 Thailand Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.4 Latin America
9.4.1 Swot Analysis:
9.4.2 Key Regional Dynamics
9.4.2.1 Latin America Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.4.3 Brazil
9.4.3.1 Target Disease Prevalence
9.4.3.2 Competitive Scenario
9.4.3.3 Regulatory Framework
9.4.3.4 Reimbursement Scenario
9.4.3.5 Brazil Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.4.4 Mexico
9.4.4.1 Target Disease Prevalence
9.4.4.2 Competitive Scenario
9.4.4.3 Regulatory Framework
9.4.4.4 Reimbursement Scenario
9.4.4.5 Mexico Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.4.5 Argentina
9.4.5.1 Target Disease Prevalence
9.4.5.2 Competitive Scenario
9.4.5.3 Regulatory Framework
9.4.5.4 Reimbursement Scenario
9.4.5.5 Argentina Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5 Middle East & Africa (MEA)
9.5.1 SWOT ANALYSIS:
9.5.2 KEY regional DYNAMICS
9.5.2.1 Middle East & Africa Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5.3 SOUTH AFRICA
9.5.3.1 Target Disease Prevalence
9.5.3.2 Competitive Scenario
9.5.3.3 Regulatory Framework
9.5.3.4 Reimbursement Scenario
9.5.3.5 south Africail Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5.4 Saudi Arabia
9.5.4.1 Target Disease Prevalence
9.5.4.2 Competitive Scenario
9.5.4.3 Regulatory Framework
9.5.4.4 Reimbursement Scenario
9.5.4.5 Saudi Arabia Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5.5 UAE
9.5.5.1 Target Disease Prevalence
9.5.5.2 Competitive Scenario
9.5.5.3 Regulatory Framework
9.5.5.4 Reimbursement Scenario
9.5.5.5 UAE Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5.6 Kuwait
9.5.6.1 Target Disease Prevalence
9.5.6.2 Competitive Scenario
9.5.6.3 Regulatory Framework
9.5.6.4 Reimbursement Scenario
9.5.6.5 Kuwait Cell & Gene Therapy Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 10 Gene Synthesis Market: Company Profiling
10.1 Company Profiles
10.1.1 GenScript
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 Brooks Automation, Inc. (GENEWIZ)
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Boster Biological Technology
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 Twist Bioscience
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 ProteoGenix, Inc.
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 Biomatik
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 ProMab Biotechnologies, Inc.
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 Thermo Fisher Scientific, Inc.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 Integrated DNA Technologies, Inc.
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 OriGene Technologies, Inc.
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.2 List of Other Key Players
|
| ※본 조사보고서 [세계의 유전자 합성 시장 (2023-2030) : 방법별 (고상 합성법, 칩 합성법, PCR 기반 효소 합성법), 서비스별, 용도별, 최종 용도별, 지역별] (코드 : GRV23MA101) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 유전자 합성 시장 (2023-2030) : 방법별 (고상 합성법, 칩 합성법, PCR 기반 효소 합성법), 서비스별, 용도별, 최종 용도별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
